An interesting case of COVID induced multi system inflammatory syndrome

Authors

  • G. S. Sanjay Surya Department of General Medicine, Saveetha Medical College Hospital, Chennai, Tamil Nadu, India
  • Priya Venugopalan Department of General Medicine, Saveetha Medical College Hospital, Chennai, Tamil Nadu, India
  • Gowtham Hanumanram Department of General Medicine, Saveetha Medical College Hospital, Chennai, Tamil Nadu, India
  • Deepthi Mithra Department of General Medicine, Saveetha Medical College Hospital, Chennai, Tamil Nadu, India
  • Gowrishankar A. Department of General Medicine, Saveetha Medical College Hospital, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20222667

Keywords:

COVID induced MIS, COVID-19, MIS, COVID complications

Abstract

COVID-19 derives from infection with Coronavirus [severe acute respiratory syndrome (SARS)-CoV-2] is associated with high morbidity and mortality. These hazardous impacts are due to the release of a storm of pro-inflammatory cytokines and thrombogenic agents. Increasing evidences about multi organ involvement in COVID infection have started pouring in, where patients who either recovered from or had mild symptoms after COVID-19, exhibit diffuse multi organ related symptoms. We describe a case of a 23-year-old male who presented to emergency room with intermittent high-grade fever, sudden onset of breathlessness, giddiness and weakness. His COVID RTPCR was negative. He was unvaccinated but his covid antibodies were increased multifold. Further examination revealed active multi organ involvement which suggestive for multisystem inflammatory syndrome (MIS). With appropriate diagnosis and treatment patient improved clinically over a course of 3 weeks and discharged and is under regular follow up.

References

Johns Hopkins University and Medicine. Coronavirus resource center. Available at: Http://Coronavirus.jhu.edu/map.html. Accessed on 25 June, 2022.

Morris SB, Schwartz NG, Patel P. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection-United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40);1450-56.

Theocharis P, Wong J, Pushparajah K. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19. Eur Heart J Cardiovasc Imaging. 2020;7;jeaa212.

Greenhalgh T, Knight M, A’Court M, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026.

Tenforde M, Kim S, Lindsell C, Billig Rose E, Shapiro NI, Files DC et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network-United States. 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993-8.

COVID-19-Long-Term-Health-Effects. Available at: https://www.gov.uk/government/publications/covid-19-long-termhealth-effects/covid-19-long-term-health-effects. Accessed on 7 May 2021.

Carvalho-Schneider C, Laurent E, Lemaignen A, Lemaignen A, Beaufils E, Bourbao-Tournois C et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27:258-63.

Vogel TP, Top KA, Karatzios C, Hilmers DC, Tapia LI, Moceri P et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;39(22):3037-49.

Patel P, DeCuir J, Abrams J, Campbell AP, Godfred-Cato S, Belay ED. Clinical characteristics of multisystem inflammatory syndrome in adults: A systematic review. JAMA network open. 2021;4(9):e2126456.

Henderson LA, Canna SW, Friedman KG. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19. Arthritis Rheumatol. 2020;72:1791.

Downloads

Published

2022-10-26

Issue

Section

Case Reports